Year of investment:
Priveq Investment VI
+46 8 24 36 60
FrostPharma is an entrepreneurial Swedish pharmaceutical company specializing in the commercialization of value-adding medicines and healthcare consumables, for which there is a specific and well-defined need.
Since the start in 2017, FrostPharma has successfully commercialized a broad range of products across multiple disease areas throughout the Nordic region and the Baltics. Key to this success has been the ability to match specific patient and health care needs with relevant products, in combination with the in-house expertise in sales and marketing to quickly generate sales.
FrostPharma is headquartered in Stockholm.
Members of the Board
Rolf Classon (Chairman of the Board), Christer Ahlberg, Clas Lindbergson, Karl-Johan Willén, Louise Nilsson
Karl-Johan Willén, Louise Nilsson, Daniel Nylund